Daye’s Post

“For a long time, there was this mistaken idea that women are basically small men, except of course for reproduction … This oversimplification can lead to harm. It is already harder to recognize, diagnose and treat women with heart disease because there are a lot of things about the physiology of women we don’t know or fully understand. And training AI with limited data and variables could actually perpetuate this problem.” — Alicia Chong Rodriguez, co-founder Bloomer Tech. Heart disease is still the No. 1 killer of women. This chart highlights the risk factors that specifically impact women. It’s from an article in The Washington Post that also features some of the female entrepreneurs tackling heart health (tagged below). Check it out here: https://lnkd.in/eBirJA5E. Maayan Cohen, founder of Hello Heart | Alicia Chong Rodríguez and Aceil Halaby co-founders of Bloomer Tech | Dr. Kathy E. Magliato MD, MBA, FACS and Michael Whitt co-founders of Cordex Systems Inc. | FemTech Focus #womenshealth #hearthealth #heartdisease

What's the biggest myth in clinical trials that needs debunking? Atlantia's Medical Study Manager, Dr Onthatile Serehete sets the record straight in the latest episode of "Clinic on Cue!". She also talks Diversity & Inclusion, Remote Trials, and AI. Catch the full episode here 👉https://hubs.la/Q02wVLsD0 #clinicaltrials #cliniconcue #atlantiaclinicaltrials#clinicaltrials

With many women skipping essential healthcare visits and facing barriers when discussing intimate health issues, our partnership with Bayer offers a vital solution. Through our AI-powered symptom assessment, over 430,000 women have already understand the possible cause of their symptoms and which treatment options may be appropriate. The result? More empowered women, greater access to care, and higher engagement with Bayer’s intimate health products. This is just the beginning of our commitment to making healthcare more accessible for all people. Learn how we're working together to support women’s intimate health: https://bit.ly/4cF2ux0

🔍 The problem: Vaginal infections affect 70% of women during reproductive age, with over 40% experiencing recurrent infections. Yet, many women feel uncomfortable seeking medical treatment, leading to missed diagnoses—only 26% correctly self-diagnose yeast infections. 💡 The solution: Bayer partnered with Ada on our symptom assessment, empowering women to understand their symptoms and take informed steps toward treatment and care. Our AI-powered platform bridges the gap in women’s health by offering accurate, trustworthy insights. 👉 Learn more about our partnership with Bayer and how we're transforming women’s health: https://bit.ly/4cF2ux0

Women's health diagnostics have been stuck in the past for far too long. But we all can change that, and I'm really excited to be at the forefront of this revolution! By combining centuries-old knowledge about the changes in salivary crystallization during the reproduction cycle with cutting-edge AI recognition technology, Ovul isn't just improving diagnostics — we're transforming lives. What are the biggest challenges you face in obtaining accurate and timely diagnostic information for women's health? #WomensHealth #HealthTech #Innovation #diagnostics

In case you missed it, check out the “Partnering for Progress - Leveraging Patient Advocacy Groups for Better Outcomes” webinar with Naomi Litchfield 🧑⚕️🤩 and Professor Rohit Shankar MBE 👨⚕️🤩, and led by Julie Powell and Matt Powell from Phormulate! #epilepsy #medtech #patientadvocacy RARE Revolution Magazine Patient Advocacy Patients As Partners in Clinical Research Community News DKSH Patient Solutions

I attended this webinar recently, discussing the roles of patient advocacy groups and how the patient should literally come first in planning any future trials. Well worth a watch.

In this expansive world 🌍 where opportunities are limitless, how about choosing to be an entity that prioritizes and champions science-based female health? 🥇 💥It's rather disconcerting that over 85% of femtech apps fail to meet the accuracy and quality thresholds, mostly due to lack of comprehensive research and adequate clinical trials. 🆕Case in point, the Qvin pad had to spark the creation of an entirely new category within the FDA to receive its approval 🤯 This uncovers a worrying reality about the safety regulations that supposedly uphold our health industry; they aren't calibrated for female physiology. Isn't it time to recalibrate the scales? What do you think? 👇 #FemaleHealth #TransformativeChange #HealthTech #WomensHealth #FridayMeme

The latest episode of "Your Gut Knows" podcast by SANNO, shining a light on the data gaps in women's health.. The gaps in clinical research: treating women as smaller versions of men 🤯. SANNO is dedicated to addressing these data gaps by analyzing symptoms and identifying comorbidities in women's health. Listen to it now, more details below! #WomensHealth #HealthEquity #AIinHealthcare #FemTech #ClinicalResearch #YourGutKnows #MedicalResearch #HealthTech #HealthData Ariadna Masó

#Techquity in #clinicaltrials This week we explore DATA from trial collaborations to better understand using technology as a bridge for access and equity in clinical trials. Join the conversation this Friday 12-1p, and RSVP with the link below.